Breast cancer trial results may not translate to real-world outcomes based on treatment discontinuation

By | June 21, 2022
New research in the June 2022 issue of JNCCN-;Journal of the National Comprehensive Cancer Network raises issues with clinical trial findings that show adjuvant hormone therapy (AHT)-related hot flashes predict better outcomes for estrogen receptor-positive (ER+) breast cancer.